Recalls & Warnings April 08, 2003 FDA Acts Against Potentially Risky Products Illegally Marketed as Street Drug Alternatives On March 31, the Food and Drug Administration (FDA) announced enforcement actions against firms that are marketing street drug alternative products, some of which contain ephedra or other sources of ephedrine
Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol
On the other hand, 35 microRNAs were identified in oocytes at the MII stage, including miR-144, miR-1603, miR-190b, miR-29b, miR-29c, miR-29e, miR-412, and miR-449b
It belongs to a new class of drugs known as triple agonists, which sets it apart from existing treatments
